Cargando…
Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissue.
The concentration of c-erbB-2 oncogene-encoded protein (p185neu) in fresh tumour samples obtained at the time of surgery from 94 non-small-cell lung cancer patients (NSCLC) was determined by an enzyme immunoassay. The relative prognostic importance was estimated, and the influence of other predictor...
Autores principales: | Diez, M., Pollán, M., Maestro, M., Torres, A., Ortega, D., Gómez, A., Sánchez, A., Hernando, F., Balibrea, J. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063350/ https://www.ncbi.nlm.nih.gov/pubmed/9043025 |
Ejemplares similares
-
Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer.
por: Díez, M., et al.
Publicado: (1996) -
Transmembrane Domain Sequence Requirements for Activation of the p185(c-neu) Receptor Tyrosine Kinase
por: Chen, Lucinda I., et al.
Publicado: (1997) -
p185(HER‐2/neu) and p21(CIP1/WAF1) Expression in Primary Tumors and Lymph Node Metastases in Non‐small Cell Lung Cancer
por: Akita, Kenji, et al.
Publicado: (2002) -
PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185(erbB2/neu) Tumor Immunotherapy
por: Nagai, Yasuhiro, et al.
Publicado: (2019) -
The levels of $^{185}$Ir populated in the decay of $^{185m+g}$Pt
por: Schück, C, et al.
Publicado: (1979)